Mediastinal (thymic) large B-cell lymphoma, intra-abd nodes is a rare and aggressive form of non-Hodgkin lymphoma characterized by the proliferation of large B-cells in the mediastinum and abdominal lymph nodes. This condition is clinically significant due to its rapid progression and potential for systemic involvement. Accurate coding with ICD-10 Code C85.23 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat affected patients.
ICD-10 Code C85.23 specifically identifies Mediastinal (thymic) large B-cell lymphoma, intra-abd nodes, a subtype of diffuse large B-cell lymphoma. This code is used when documenting cases where large B-cells are present in the mediastinal region and intra-abdominal lymph nodes. It is crucial for accurate clinical documentation and billing, particularly when distinguishing this aggressive lymphoma from other lymphoproliferative disorders.
Mediastinal (thymic) large B-cell lymphoma, intra-abd nodes is primarily caused by genetic mutations leading to uncontrolled proliferation of B-lymphocytes. The condition can progress rapidly, often presenting with significant symptoms that necessitate immediate medical intervention. Early diagnosis and treatment are critical to improving patient outcomes.
ICD-10 Code C85.23 is utilized in SOAP notes to document the diagnosis of Mediastinal (thymic) large B-cell lymphoma, intra-abd nodes. This code plays a vital role in capturing patient symptoms, assessments, and treatment plans, ensuring comprehensive documentation in both acute and chronic care settings.
In SOAP notes, ICD-10 Code C85.23 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Mediastinal (thymic) large B-cell lymphoma, intra-abd nodes. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Mediastinal (thymic) large B-cell lymphoma, intra-abd nodes requires prompt medical attention and often hospitalization for treatment. Standard approaches include chemotherapy and, in some cases, radiation therapy.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C85.23 is crucial for accurate billing in hospital, ER, or infectious disease care settings, ensuring proper reimbursement for services rendered.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push technique. |
| 99223 | Initial hospital care, typically 70 minutes or more. |
| 85025 | Complete blood count with differential. |
Common Questions About Using ICD-10 Code C85.23 for Mediastinal (thymic) large B-cell lymphoma, intra-abd nodes
What are the common symptoms of Mediastinal (thymic) large B-cell lymphoma?
Common symptoms include chest pain, abdominal discomfort, unexplained weight loss, night sweats, and fatigue. These symptoms may indicate the need for further evaluation and diagnostic imaging.
How is Mediastinal (thymic) large B-cell lymphoma treated?
Treatment typically involves chemotherapy, often with a regimen such as R-CHOP, and may include radiation therapy for localized disease. Supportive care is also important to manage symptoms.
When should ICD-10 Code C85.23 be used?
ICD-10 Code C85.23 should be used when documenting cases of Mediastinal (thymic) large B-cell lymphoma with involvement of intra-abdominal lymph nodes, ensuring accurate representation of the patient's condition.
What is the prognosis for patients with Mediastinal (thymic) large B-cell lymphoma?
The prognosis can vary based on factors such as the stage of the disease at diagnosis and the patient's overall health. Early detection and treatment are crucial for improving outcomes.
Clinical Notes
SOAP notes
DAP notes
AI medical notes